Elicera Therapeutics
Phase 1/2Elicera Therapeutics develops cell and gene therapies in immuno-oncology
Founded
2014
Focus
RNA & Gene TherapyCell & Gene Therapy
About
Elicera Therapeutics develops cell and gene therapies in immuno-oncology
Company Info
TypePrivate
Founded2014
LocationUppsala, Sweden
StagePhase 1/2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile